Stimusil

Wilmington, DE · Founded 2021 · Privately Held (backing)

Operator of a medical device company intended to develop proprietary methods for subdermal photobiomodulation. Stimusil is based in Wilmington, DE and was founded in 2021. Its last reported valuation was $29.2 million in Aug 2023. It has raised $10.3 million across 3 recorded rounds; the latest was a $599,988 seed round in Dec 2024.

Last reported valuation
$29.2M
Oct 2026
Priced at
—
Total raised
$10.3M
Last round
Seed Round
Dec 2024

Who backs Stimusil?

3 investors
InvestorType
Toubkal PartnersVenture capital
Gen Ilac Ve Saglik—
Northwestern University—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Stimusil investors

3 investors are on record for Stimusil, including Toubkal Partners, Gen Ilac Ve Saglik and Northwestern University. The seed round in Dec 2024 drew 2 investors.

Free account
More of Stimusil with a free account
  • ·Watch Stimusil: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 3 firms already write checks for companies like Stimusil. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View